-
1.Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation 失效
标题翻译: 乙缩醛苄基甲基纤维素作为平滑肌细胞增殖的抑制剂公开(公告)号:US06340670B1
公开(公告)日:2002-01-22
申请号:US09447009
申请日:1999-11-22
IPC分类号: A61K31702
CPC分类号: C07H15/203
摘要: This invention provides smooth muscle cell proliferation inhibitors of formula I having the structure with the variables defined herein.
摘要翻译: 本发明提供具有本文定义的变量的结构的式I的平滑肌细胞增殖抑制剂。
-
2.Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation 失效
标题翻译: 作为平滑肌细胞增殖的抑制剂的酰化苄基甲基卤化物公开(公告)号:US07514411B2
公开(公告)日:2009-04-07
申请号:US11505543
申请日:2006-08-17
IPC分类号: A61K31/702 , C07H15/203
CPC分类号: C07H17/02 , A61K31/704 , C07H5/06
摘要: This invention provides smooth muscle cell proliferation inhibitors of formula I having the structure wherein R1, R2, R3, R4, R5, R6, R7, W, Y, and Z are defined herein; or a pharmaceutically acceptable salt thereof.
摘要翻译: 本发明提供具有其中R1,R2,R3,R4,R5,R6,R7,W,Y和Z在本文中定义的结构的式I的平滑肌细胞增殖抑制剂; 或其药学上可接受的盐。
-
3.2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia 失效
标题翻译: 用于治疗胰岛素抵抗和高血糖症的2,3,5-取代联苯公开(公告)号:US07008636B2
公开(公告)日:2006-03-07
申请号:US10843026
申请日:2004-05-11
申请人: John A. Butera , Craig E. Caufield , Russell F. Graceffa , Alexander Greenfield , Eric G. Gundersen , Lisa Marie Havran , Alan H. Katz , Joseph R. Lennox , Scott C. Mayer , Robert E. McDevitt
发明人: John A. Butera , Craig E. Caufield , Russell F. Graceffa , Alexander Greenfield , Eric G. Gundersen , Lisa Marie Havran , Alan H. Katz , Joseph R. Lennox , Scott C. Mayer , Robert E. McDevitt
IPC分类号: A61K31/343 , A61K31/19 , C07D307/78 , C07C53/134
CPC分类号: C07D213/40 , C07C17/16 , C07C45/68 , C07C45/71 , C07C47/575 , C07C205/35 , C07C205/37 , C07C309/77 , C07D209/08 , C07D233/54 , C07D263/58 , C07D307/58 , C07D307/80 , C07D307/81 , C07D317/54 , C07D333/74 , C07D413/12 , C07F9/4006 , C07C22/04
摘要: This invention provides compounds of Formula I having the structure or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.
摘要翻译: 本发明提供了具有结构或其可药用盐的式I化合物,其可用于治疗与胰岛素抵抗或高血糖相关的代谢紊乱。
-
4.2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia 失效
标题翻译: 用于治疗胰岛素抵抗和高血糖症的2,3,5-取代联苯公开(公告)号:US06451827B2
公开(公告)日:2002-09-17
申请号:US09771469
申请日:2001-01-26
申请人: John A. Butera , Craig E. Caufield , Russell F. Graceffa , Alexander Greenfield , Eric G. Gundersen , Lisa Marie Havran , Alan H. Katz , Joseph R. Lennox , Scott C. Mayer , Robert E. McDevitt
发明人: John A. Butera , Craig E. Caufield , Russell F. Graceffa , Alexander Greenfield , Eric G. Gundersen , Lisa Marie Havran , Alan H. Katz , Joseph R. Lennox , Scott C. Mayer , Robert E. McDevitt
IPC分类号: A61K3144
CPC分类号: C07D213/40 , C07C17/16 , C07C45/68 , C07C45/71 , C07C47/575 , C07C205/35 , C07C205/37 , C07C309/77 , C07D209/08 , C07D233/54 , C07D263/58 , C07D307/58 , C07D307/80 , C07D307/81 , C07D317/54 , C07D333/74 , C07D413/12 , C07F9/4006 , C07C22/04
摘要: This invention provides compounds of Formula I having the structure wherein: B, C, D, and R1 are as defined hereinbefore in the specification, or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.
摘要翻译: 本发明提供具有结构的式I化合物,其中B,C,D和R 1如本说明书中所定义,或其药学上可接受的盐,其可用于治疗与胰岛素抵抗或高血糖相关的代谢紊乱。
-
5.2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia 失效
标题翻译: 用于治疗胰岛素抵抗和高血糖症的2,3,5-取代联苯公开(公告)号:US06765021B2
公开(公告)日:2004-07-20
申请号:US10215438
申请日:2002-08-09
申请人: John A. Butera , Craig E. Caufield , Russell F. Graceffa , Alexander Greenfield , Eric G. Gundersen , Lisa Marie Havran , Alan H. Katz , Joseph R. Lennox , Scott C. Mayer , Robert E. McDevitt
发明人: John A. Butera , Craig E. Caufield , Russell F. Graceffa , Alexander Greenfield , Eric G. Gundersen , Lisa Marie Havran , Alan H. Katz , Joseph R. Lennox , Scott C. Mayer , Robert E. McDevitt
IPC分类号: A61K3117
CPC分类号: C07F9/4006 , C07B2200/07 , C07C17/16 , C07C45/68 , C07C45/71 , C07C47/575 , C07C205/35 , C07C205/37 , C07C225/20 , C07C233/43 , C07C235/46 , C07C235/48 , C07C235/52 , C07C237/30 , C07C255/54 , C07C271/12 , C07C271/16 , C07C271/28 , C07C271/30 , C07C309/77 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07D209/08 , C07D213/40 , C07D233/54 , C07D263/58 , C07D295/088 , C07D295/13 , C07D307/58 , C07D307/80 , C07D307/81 , C07D317/54 , C07D333/74 , C07D413/12 , C07C22/04
摘要: This invention provides compounds of formula I having the structure wherein: B, D, C, and R1 as defined herein.
摘要翻译: 本发明提供具有本文定义的B,D,C和R 1结构的式I化合物。
-
6.2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia 失效
标题翻译: 用于治疗胰岛素抵抗和高血糖症的2,3,5-取代联苯公开(公告)号:US06214877B1
公开(公告)日:2001-04-10
申请号:US09307850
申请日:1999-05-10
申请人: John A. Butera , Craig E. Caufield , Russell F. Graceffa , Alexander Greenfield , Eric G. Gundersen , Lisa Marie Havran , Alan H. Katz , Joseph R. Lennox , Scott C. Mayer , Robert E. McDevitt
发明人: John A. Butera , Craig E. Caufield , Russell F. Graceffa , Alexander Greenfield , Eric G. Gundersen , Lisa Marie Havran , Alan H. Katz , Joseph R. Lennox , Scott C. Mayer , Robert E. McDevitt
IPC分类号: A61K31166
CPC分类号: C07F9/4006 , C07B2200/07 , C07C17/16 , C07C45/68 , C07C45/71 , C07C47/575 , C07C205/35 , C07C205/37 , C07C225/20 , C07C233/43 , C07C235/46 , C07C235/48 , C07C235/52 , C07C237/30 , C07C255/54 , C07C271/12 , C07C271/16 , C07C271/28 , C07C271/30 , C07C309/77 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07D209/08 , C07D213/40 , C07D233/54 , C07D263/58 , C07D295/088 , C07D295/13 , C07D307/58 , C07D307/80 , C07D307/81 , C07D317/54 , C07D333/74 , C07D413/12 , C07C22/04
摘要: This invention provides compounds of Formula I having the structure wherein: B, C, D, and R1 are as defined hereinbefore in the specification, or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.
摘要翻译: 本发明提供具有结构的式I化合物,其中B,C,D和R 1如本说明书中所定义,或其药学上可接受的盐,其可用于治疗与胰岛素抵抗或高血糖相关的代谢紊乱。
-
7.
公开(公告)号:US06664243B1
公开(公告)日:2003-12-16
申请号:US09444736
申请日:1999-11-22
申请人: Scott C. Mayer
发明人: Scott C. Mayer
IPC分类号: A61K31715
CPC分类号: C07H15/203
摘要: This invention provides smooth muscle cell proliferation inhibitors of formula I having the structure wherein R1-R13 are as defined herein.
摘要翻译: 本发明提供具有结构的式I的平滑肌细胞增殖抑制剂,其中R 1 -R 13如本文所定义。
-
-
-
-
-
-